Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001901496 | SCV002168496 | uncertain significance | Aortic valve disease 2 | 2023-05-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1404142). This premature translational stop signal has been observed in individual(s) with ATR-16 syndrome (PMID: 32005695). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg12*) in the SMAD6 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SMAD6 cause disease. |
Gene |
RCV003329420 | SCV004036300 | likely pathogenic | not provided | 2023-03-22 | criteria provided, single submitter | clinical testing | Reported in individuals from a single family who also harbored a 16p13.3 deletion and had features of alpha-thalassemia/impaired intellectual development syndrome (Babbs et al., 2020); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32005695) |